BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2024; 12(22): 5258-5262
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5258
Giant retroperitoneal hemolymphangioma: A case report and review of literature
Yi-Kai Wang, Ying-Hao Liu, Wei-Bing Shuang
Yi-Kai Wang, Ying-Hao Liu, Wei-Bing Shuang, Department of Urology, The First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
Author contributions: Shuang WB designed the research study; Wang YK and Liu YH performed the research; Wang YK contributed new reagents and analytic tools; Wang YK and Shuang WB analyzed the data and wrote the manuscript; All authors have read and approved the final manuscript.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare no competing interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Wei-Bing Shuang, PhD, Chief Physician, Instructor, Department of Urology, The First Hospital of Shanxi Medical University, No. 85 JieFang South Road, Yingze District, Taiyuan 030001, Shanxi Province, China. shuangweibing@126.com
Received: April 25, 2024
Revised: May 23, 2024
Accepted: June 11, 2024
Published online: August 6, 2024
Processing time: 68 Days and 7.6 Hours
Core Tip

Core Tip: The clinical features of hemolymphangioma are often atypical, and it is easy to miss and misdiagnose. When the time of nuclear magnetic T1 is significantly reduced, the diagnosis of hemolymphangioma should be considered. Retroperitoneal hemolymphangiomas are usually very large and puncture drainage can be an early treatment option.